Figure 2.
CAR-T-cell therapy and immune checkpoint inhibitors activate T cells, leading to a cytokine storm. The excessive circulating cytokine levels lead to capillary leak syndrome. CAR-T, chimeric antigen receptor-T.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.